跳至主要内容
临床试验/NCT02308865
NCT02308865终止不适用

Impact of Early Palliative Care on Quality of Life and Survival of Patients With Non-small-cell Metastatic Lung Cancer in Northern France

University Hospital, Lille2 个研究点 分布在 1 个国家目标入组 71 人开始时间: 2014年10月17日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
入组人数
71
试验地点
2
主要终点
quality of life

研究概览

简要总结

Single-center, prospective, controlled, open-label, randomized, two parallel arms comparing early Palliative care versus Standard care in patients with non-small-cell metastatic lung cancer

详细描述

144 patients will be included; 72 per arm.

  • "Standard" Control arm: patient supported by the onco-respiratory service.
  • Intervention arm: patients benefit from early palliative care in addition to standard onco-pneumologic care.

The main criterion of judgment is the TOI score measured at 12 weeks.

FACTL questionnaires, HADS and PHQ-9 will be filled out before randomization , at 12 weeks and 21 weeks

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Being diagnosed with non-small cell lung cancer
  • Proven histologically
  • Metastatic proven imaging (MRI, CT Scanner, PET scan)
  • Stage IV (any T, any N, M1)
  • prior to secondary chemotherapy treatment.
  • Age> 18 years
  • Patient able to understand the nature, purpose and methodology of the study
  • signed Informed consent

排除标准

  • Age <18 years
  • Patient already supported by palliative care
  • Patient with an activating EGFR mutation or EML4-ALK rearrangement or ROS1 gene translocation
  • Patient under trusteeship / guardianship

研究组 & 干预措施

Control arm

No Intervention

Patient supported by the onco respiratory service for the treatment of their disease by chemotherapy and for the treatment of complications.

intervention arm

Experimental

Multi disciplinary palliative care monthly consultations with a doctor, a nurse, a psychologist and posibility of a physical therapist and a chaplain in addition to standard onco-pneumologic care.

干预措施: multi disciplinary palliative care monthly consultations (Other)

结局指标

主要结局

quality of life

时间窗: 12 weeks

quality of life is measured at 12 weeks by the TOI score

次要结局

  • EVENTS(14 days before deaths)
  • QUALITY OF LIFE(12 and 21 weeks)
  • SURVIVAL(from baseline)

研究者

发起方
University Hospital, Lille
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验